Renata Pereira Sustovich Pugliese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renata Pereira Sustovich Pugliese has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Antunes Fonseca
Hepatology and Liver Transplantation Hospital Sírio‐Libanês São Paulo Brazil
6 shared publications - Joao Seda Neto
Hepatology and Liver Transplantation Hospital Sírio‐Libanês São Paulo Brazil
6 shared publications - Carolina Magalhães Costa
Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, Brazil
5 shared publications - Gilda Porta
Hepatology and Liver Transplantation Hospital Sírio‐Libanês and Hospital Samaritano São Paulo Brazil
5 shared publications - Flávia Heinz Feier
Universidade Federal do Rio Grande do Sul
3 shared publications - Irene Kazue Miura
Hepatology and Liver Transplantation Hospital Sírio‐Libanês and Hospital Samaritano São Paulo Brazil
3 shared publications
Latest Publications
- 27 August 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (9)
Thickness Reduction Versus Conventional Left Lateral Sector Strategies in Children Below 8 kg Undergoing Living Donor Liver Transplantation
Background: Liver transplantation in children weighing < 8 kg carries a high risk of graft–recipient size mismatch, particularly excessive graft anteroposterior (AP) thickness, which may impair abdominal closure and graft perfusion. Graft thickness reduction (TR) has been proposed to address this issue; however, objective criteria guiding its indication remain poorly defined. This study compared outcomes between thickness‐reduced grafts and left lateral segment (LLS) grafts and explored factors associated with TR use. Methods: We retrospectively analyzed 79 primary living‐donor liver transplants performed in recipients weighing < 8 kg between January 2017 and July 2025. Patients were divided into LLS/standard‐reduced LLS (LLS/SR‐LLS, n = 46) and thickness reduction by anterior hepatic resection (TR‐AHR, n = 33). Recipient, donor, intraoperative, and postoperative variables were compared. Results: Recipients in the TR‐AHR group were younger, while body weight and PELD were similar between groups. Donors in the TR‐AHR group were more frequently male and had higher body weight and BMI. TR‐AHR achieved significantly lower final graft weight, graft‐to‐recipient weight ratio, and AP diameter. Rates of primary abdominal closure, ICU and hospital length of stay, vascular and biliary complications, and patient survival were comparable. Donor male sex, higher donor body weight and BMI, increased DWRWR, larger estimated AP diameter, and higher estimated GRWR were associated with TR‐AHR use. Conclusion: TR‐AHR is a safe and effective strategy to manage graft–recipient size mismatch in recipients < 8 kg, achieving favorable graft dimensions without increasing morbidity. Identified variables should be interpreted as practical markers rather than formal selection criteria. Larger multicenter studies are needed to define standardized indications and long‐term outcomes.
- 27 August 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (9)
Thickness Reduction Versus Conventional Left Lateral Sector Strategies in Children Below 8 kg Undergoing Living Donor Liver Transplantation
Background: Liver transplantation in children weighing < 8 kg carries a high risk of graft–recipient size mismatch, particularly excessive graft anteroposterior (AP) thickness, which may impair abdominal closure and graft perfusion. Graft thickness reduction (TR) has been proposed to address this issue; however, objective criteria guiding its indication remain poorly defined. This study compared outcomes between thickness‐reduced grafts and left lateral segment (LLS) grafts and explored factors associated with TR use. Methods: We retrospectively analyzed 79 primary living‐donor liver transplants performed in recipients weighing < 8 kg between January 2017 and July 2025. Patients were divided into LLS/standard‐reduced LLS (LLS/SR‐LLS, n = 46) and thickness reduction by anterior hepatic resection (TR‐AHR, n = 33). Recipient, donor, intraoperative, and postoperative variables were compared. Results: Recipients in the TR‐AHR group were younger, while body weight and PELD were similar between groups. Donors in the TR‐AHR group were more frequently male and had higher body weight and BMI. TR‐AHR achieved significantly lower final graft weight, graft‐to‐recipient weight ratio, and AP diameter. Rates of primary abdominal closure, ICU and hospital length of stay, vascular and biliary complications, and patient survival were comparable. Donor male sex, higher donor body weight and BMI, increased DWRWR, larger estimated AP diameter, and higher estimated GRWR were associated with TR‐AHR use. Conclusion: TR‐AHR is a safe and effective strategy to manage graft–recipient size mismatch in recipients < 8 kg, achieving favorable graft dimensions without increasing morbidity. Identified variables should be interpreted as practical markers rather than formal selection criteria. Larger multicenter studies are needed to define standardized indications and long‐term outcomes.
- Open Access
- 21 October 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (7) , e70212
Double Versus Single Hepatic Artery Anastomosis in Pediatric Left Liver Grafts: A Reassessment of Outcomes
Background: The primary goal of hepatic artery reconstruction is to restore blood flow to the liver graft and its biliary system. Surgical approaches vary in the number of arterial anastomoses, magnification techniques, and anticoagulation strategies. This study analyzes the anatomical approaches used for arterial reconstruction, the incidence of HAT, and associated risk factors. Method: A retrospective study of 489 primary pediatric LDLT performed between January 2017 and July 2024. Results: The incidence rates of HAT, early portal vein thrombosis (EPVT), late‐PVT, biliary leak (BL), and biliary stricture (BS) were 1% ( n = 5), 1.4% ( n = 7), 4.3% ( n = 21), 15% ( n = 73), and 11.9% ( n = 58), respectively. Double HA anastomosis was performed in 29.4% (119/405) of cases, with LHA‐LHA + MHA‐RHA being the most frequent combination. HAT occurred in four patients (1.4%) with single HA anastomosis and one patient (0.8%) in the double HA group ( p = 1.00). The rates of BS and BL in the single HA group were 14.7% ( n = 51) and 12.1% ( n = 42), respectively, compared to 16% ( n = 21) and 10.7% ( n = 14) in the double HA group (BS: p = 0.72, BL: p = 0.66). Increasing age, CIT, and secondary abdominal closure were associated with higher HAT risk. The overall survival rate was 94.6%, with a median follow‐up of 50.7 months (IQR: 21.1–73). Conclusion: This study showed a low HAT rate (1%) with increasing age, CIT, and secondary abdominal closure as risk factors. Double HA anastomosis did not reduce biliary complications. The most common HA graft‐recipient combinations in this study were LHA‐RHA for single HA reconstruction and LHA‐LHA + MHA‐RHA for double HA reconstruction.
- 21 October 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (7) , e70212
Open AccessDouble Versus Single Hepatic Artery Anastomosis in Pediatric Left Liver Grafts: A Reassessment of Outcomes
Background: The primary goal of hepatic artery reconstruction is to restore blood flow to the liver graft and its biliary system. Surgical approaches vary in the number of arterial anastomoses, magnification techniques, and anticoagulation strategies. This study analyzes the anatomical approaches used for arterial reconstruction, the incidence of HAT, and associated risk factors. Method: A retrospective study of 489 primary pediatric LDLT performed between January 2017 and July 2024. Results: The incidence rates of HAT, early portal vein thrombosis (EPVT), late‐PVT, biliary leak (BL), and biliary stricture (BS) were 1% ( n = 5), 1.4% ( n = 7), 4.3% ( n = 21), 15% ( n = 73), and 11.9% ( n = 58), respectively. Double HA anastomosis was performed in 29.4% (119/405) of cases, with LHA‐LHA + MHA‐RHA being the most frequent combination. HAT occurred in four patients (1.4%) with single HA anastomosis and one patient (0.8%) in the double HA group ( p = 1.00). The rates of BS and BL in the single HA group were 14.7% ( n = 51) and 12.1% ( n = 42), respectively, compared to 16% ( n = 21) and 10.7% ( n = 14) in the double HA group (BS: p = 0.72, BL: p = 0.66). Increasing age, CIT, and secondary abdominal closure were associated with higher HAT risk. The overall survival rate was 94.6%, with a median follow‐up of 50.7 months (IQR: 21.1–73). Conclusion: This study showed a low HAT rate (1%) with increasing age, CIT, and secondary abdominal closure as risk factors. Double HA anastomosis did not reduce biliary complications. The most common HA graft‐recipient combinations in this study were LHA‐RHA for single HA reconstruction and LHA‐LHA + MHA‐RHA for double HA reconstruction.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13599
Potential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients
In this study, we identified miRNAs and their potential mRNA targets that are intricately linked to primary chemotherapy response in patients with invasive ductal carcinomas. A cohort of individuals diagnosed with advanced invasive breast ductal carcinoma who underwent primary chemotherapy served as the cornerstone of our study. We conducted a comparative analysis of microRNA expression among patients who either responded or did not respond to primary systemic therapy. To analyze the correlation between the expression of the whole transcriptome and the 24 differentially expressed (DE) miRNAs, we harnessed the extensive repository of The Cancer Genome Atlas (TCGA) database. We mapped molecular mechanisms associated with these miRNAs and their targets from TCGA breast carcinomas. The resultant expression profile of the 24 DE miRNAs emerged as a potent and promising predictive model, offering insights into the intricate dynamics of chemotherapy responsiveness of advanced breast tumors. The discriminative analysis based on the principal component analysis identified the most representative miRNAs across breast cancer samples (miR-210, miR-197, miR-328, miR-519a, and miR-628). Moreover, the consensus clustering generated four possible clusters of TCGA patients. Further studies should be conducted to advance these findings.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13599
Open AccessPotential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients
In this study, we identified miRNAs and their potential mRNA targets that are intricately linked to primary chemotherapy response in patients with invasive ductal carcinomas. A cohort of individuals diagnosed with advanced invasive breast ductal carcinoma who underwent primary chemotherapy served as the cornerstone of our study. We conducted a comparative analysis of microRNA expression among patients who either responded or did not respond to primary systemic therapy. To analyze the correlation between the expression of the whole transcriptome and the 24 differentially expressed (DE) miRNAs, we harnessed the extensive repository of The Cancer Genome Atlas (TCGA) database. We mapped molecular mechanisms associated with these miRNAs and their targets from TCGA breast carcinomas. The resultant expression profile of the 24 DE miRNAs emerged as a potent and promising predictive model, offering insights into the intricate dynamics of chemotherapy responsiveness of advanced breast tumors. The discriminative analysis based on the principal component analysis identified the most representative miRNAs across breast cancer samples (miR-210, miR-197, miR-328, miR-519a, and miR-628). Moreover, the consensus clustering generated four possible clusters of TCGA patients. Further studies should be conducted to advance these findings.
- 27 March 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (5) , e14518
Anterior hepatic resection: A simple and safe technique for reducing the antero‐posterior diameter of the liver graft for small pediatric recipients
Background: The techniques involved in neonatal and infantile transplantation require approaches that can sculpt a left lateral segment (LLS) to the right shape and size and avoid large‐for‐size syndrome. The aim of this article is to describe the anterior hepatic resection (AHR) of the LLS in pediatric LDLT.Methods: A retrospective anatomical study of preoperative image studies, description of the technique for AHR, and short‐term results.Results: The AHR was performed in eight cases. All donors were male, with average age, BW, and BMI of 28.3 ± 5.9 years, 74.2 ± 9.3 kg, and 24.3 ± 2.6 kg/m2, respectively. Donors were discharged at an average of 3.6 ± 0.8 days. The median recipient age and BW at transplantation were 6.9 (2.7 to 11) months and 5.9 (3.9 to 8) kg, respectively, and the recipient‐to‐donor body weight ratio (RDBW) was <0.1 in all but one case. The mean percentage reduction in graft weight and in the antero‐posterior diameter were 33.2% ± 5.5% and 38.3% ± 12.6%, respectively. The average (SD) GRWR was 4.8% ± 1.7% before all the resections and 3.5% ± 1.0% after the procedures. Seven patients were primarily closed.Conclusion: After LLS resection, a nonanatomical anterior resection of the LLS was accomplished without hilar vascular dissection to segments II/III. The final liver graft allowed primary abdominal wall closure in all but one patient, with meaningful adjustments in GRWR. AHR proved to be simple, safe, reproducible, and effective in the presented case series.
- 27 March 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (5) , e14518
Anterior hepatic resection: A simple and safe technique for reducing the antero‐posterior diameter of the liver graft for small pediatric recipients
Background: The techniques involved in neonatal and infantile transplantation require approaches that can sculpt a left lateral segment (LLS) to the right shape and size and avoid large‐for‐size syndrome. The aim of this article is to describe the anterior hepatic resection (AHR) of the LLS in pediatric LDLT.Methods: A retrospective anatomical study of preoperative image studies, description of the technique for AHR, and short‐term results.Results: The AHR was performed in eight cases. All donors were male, with average age, BW, and BMI of 28.3 ± 5.9 years, 74.2 ± 9.3 kg, and 24.3 ± 2.6 kg/m2, respectively. Donors were discharged at an average of 3.6 ± 0.8 days. The median recipient age and BW at transplantation were 6.9 (2.7 to 11) months and 5.9 (3.9 to 8) kg, respectively, and the recipient‐to‐donor body weight ratio (RDBW) was <0.1 in all but one case. The mean percentage reduction in graft weight and in the antero‐posterior diameter were 33.2% ± 5.5% and 38.3% ± 12.6%, respectively. The average (SD) GRWR was 4.8% ± 1.7% before all the resections and 3.5% ± 1.0% after the procedures. Seven patients were primarily closed.Conclusion: After LLS resection, a nonanatomical anterior resection of the LLS was accomplished without hilar vascular dissection to segments II/III. The final liver graft allowed primary abdominal wall closure in all but one patient, with meaningful adjustments in GRWR. AHR proved to be simple, safe, reproducible, and effective in the presented case series.
- 28 February 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (8) , 827-835
Hepatic venous reconstruction of the left lateral segment with emphasis on anomalous hepatic vein in pediatric liver transplantation
Left lateral segment grafts have become a suitable option in pediatric liver transplantation (PLT). The correlation between hepatic vein (HV) reconstruction and outcome is relevant when assessing the safe use of these grafts. We retrospectively reviewed the medical records prospectively collected from a pediatric living donor liver transplantation database and conducted a comparative analysis of the different left lateral segment graft types according to HV reconstruction. Donor, recipient, and intraoperative variables were analyzed. Post-transplant outcomes included vascular complications such as hepatic vein outflow obstruction, early (≤30 d) and late (>30 d) PVT, hepatic artery thrombosis, and graft survival. From February 2017 to August 2021, 303 PLTs were performed. According to venous anatomy, the distribution of the left lateral segment was as follows: single HV (type I) in 174 (57.4%), close HVs, simple venoplasty for reconstruction (type II) in 97 (32.01%), anomalous hepatic vein (AHV) with a distance between the HVs orifices that allowed simple venoplasty (type IIIA) in 25 (8.26%) and AHV with a distance between the HVs orifices requiring homologous venous graft interposition (type IIIB) in 07 (2.31%) grafts. Type IIIB grafts came from male donors (p=0.04) and had a higher mean donor height (p=0.008), a higher mean graft weight, and a higher graft-to-recipient weight ratio, both p=0.002. The median follow-up time was 41.4 months. The overall cumulative graft survival was 96.3%, and comparative graft survival showed no difference (log-rank p=0.61). No hepatic vein outflow obstructions were observed in this cohort study. There was no statistically significant difference in the post-transplant outcomes between the graft types. The venous reconstruction of the AHV with homologous venous graft interposition had similar outcomes in the short and long term.
- 28 February 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (8) , 827-835
Hepatic venous reconstruction of the left lateral segment with emphasis on anomalous hepatic vein in pediatric liver transplantation
Left lateral segment grafts have become a suitable option in pediatric liver transplantation (PLT). The correlation between hepatic vein (HV) reconstruction and outcome is relevant when assessing the safe use of these grafts. We retrospectively reviewed the medical records prospectively collected from a pediatric living donor liver transplantation database and conducted a comparative analysis of the different left lateral segment graft types according to HV reconstruction. Donor, recipient, and intraoperative variables were analyzed. Post-transplant outcomes included vascular complications such as hepatic vein outflow obstruction, early (≤30 d) and late (>30 d) PVT, hepatic artery thrombosis, and graft survival. From February 2017 to August 2021, 303 PLTs were performed. According to venous anatomy, the distribution of the left lateral segment was as follows: single HV (type I) in 174 (57.4%), close HVs, simple venoplasty for reconstruction (type II) in 97 (32.01%), anomalous hepatic vein (AHV) with a distance between the HVs orifices that allowed simple venoplasty (type IIIA) in 25 (8.26%) and AHV with a distance between the HVs orifices requiring homologous venous graft interposition (type IIIB) in 07 (2.31%) grafts. Type IIIB grafts came from male donors (p=0.04) and had a higher mean donor height (p=0.008), a higher mean graft weight, and a higher graft-to-recipient weight ratio, both p=0.002. The median follow-up time was 41.4 months. The overall cumulative graft survival was 96.3%, and comparative graft survival showed no difference (log-rank p=0.61). No hepatic vein outflow obstructions were observed in this cohort study. There was no statistically significant difference in the post-transplant outcomes between the graft types. The venous reconstruction of the AHV with homologous venous graft interposition had similar outcomes in the short and long term.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12671
In vitro fertilization: an unexpected finding in a cohort of patients with biliary atresia
In biliary atresia (BA), efforts to prevent premature liver transplantation (LT) are aimed at early diagnosis, timing of Kasai-portoenterostomy (KPE), and centralization of care. This report presents the clinical picture, treatment strategies, and outcomes of BA patients with no previous treatment. A retrospective cohort study (Jan/2001 to Jan/2021) was conducted to evaluate the outcome of patients with BA referred to a single team. Study groups were: 1) Kasai-only group (K-only) n=9), 2) LT-only group (n=7), and 3) Kasai+LT group (K+LT) (n=23). Survival with native liver and overall survival were 22.9 and 94.8%, respectively, at 120 months of follow-up. There was no difference in age at KPE in the K-only group (46.8±21.8 days) vs K+LT (52.1±22 days), P=0.4. Ten (25.6%) patients were babies conceived through in vitro fertilization (IVF). Four IVF patients (40%) presented associated congenital heart disease vs 5 patients (17%) in the remaining group (P=0.14). Two of the IVF patients were premature (<37 weeks). Median maternal age at birth was 35 years (33 to 41 years). Excellent patient survival is expected for patients with BA with the available treatment strategies. IVF+BA was an unexpected prevalent association in this cohort, and further studies are required to better understand these findings.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12671
Open AccessIn vitro fertilization: an unexpected finding in a cohort of patients with biliary atresia
In biliary atresia (BA), efforts to prevent premature liver transplantation (LT) are aimed at early diagnosis, timing of Kasai-portoenterostomy (KPE), and centralization of care. This report presents the clinical picture, treatment strategies, and outcomes of BA patients with no previous treatment. A retrospective cohort study (Jan/2001 to Jan/2021) was conducted to evaluate the outcome of patients with BA referred to a single team. Study groups were: 1) Kasai-only group (K-only) n=9), 2) LT-only group (n=7), and 3) Kasai+LT group (K+LT) (n=23). Survival with native liver and overall survival were 22.9 and 94.8%, respectively, at 120 months of follow-up. There was no difference in age at KPE in the K-only group (46.8±21.8 days) vs K+LT (52.1±22 days), P=0.4. Ten (25.6%) patients were babies conceived through in vitro fertilization (IVF). Four IVF patients (40%) presented associated congenital heart disease vs 5 patients (17%) in the remaining group (P=0.14). Two of the IVF patients were premature (<37 weeks). Median maternal age at birth was 35 years (33 to 41 years). Excellent patient survival is expected for patients with BA with the available treatment strategies. IVF+BA was an unexpected prevalent association in this cohort, and further studies are required to better understand these findings.
- Open Access
- 16 August 2021
- Published by Wiley in Pediatric Transplantation
- Vol. 25 (8) , e14112
Pediatric liver transplantation activity in a high‐volume program during the COVID‐19 pandemic in Brazil
Background: The impact of the COVID pandemic on liver transplant (LT) programs varied among countries. Few data are available about that impact in pediatric liver transplant (PLT) programs. This study aimed at comparing the data of our program in Brazil (2019 vs. 2020).Methods: Retrospective cohort study.Results: One hundred and seventy‐four PLT were performed in the period (93% living donors). Patients were divided into two groups according to the LT date: pre‐COVID‐19 period (march/2019–February/2020) and COVID‐19 period (March/2020–February 2021). In the pre‐COVID‐19 period, 97 LTs were performed, and 77 LTs were performed in the COVID‐19 period. Patients in the COVID‐19 period were younger (10.9 months vs. 16 months, p 0.009), had higher PELD scores (15 vs. 14, p 0.04), more ascites (66.2 vs. 51.5%, p 0.03), and more frequently hospitalized before LT (27.3 vs. 17.5%). However, there was no difference in post‐LT complications, retransplantation nor survival rates. Six (6.2%) patients from pre‐COVID‐19 period were COVID positive at a median of 15.5 months (14–17.5), and 6 (7.8%) patients from COVID‐19 period were COVID positive at a median of 3 months (20 days–6 months) from LT. There was neither mortality nor complications in those patients. Four (33%) were hospitalized, and one had prolonged intubation. Four (33%) were asymptomatic, 4 (33%) had upper airways symptoms, and the remaining had gastrointestinal symptoms.Conclusion: Overall, PLT was not affected during COVID‐19 period. Even though patients from COVID‐19 period were sicker, there was no significant impact in LT outcomes. All the recipients who tested positive for COVID had a favorable outcome.
- 16 August 2021
- Published by Wiley in Pediatric Transplantation
- Vol. 25 (8) , e14112
Open AccessPediatric liver transplantation activity in a high‐volume program during the COVID‐19 pandemic in Brazil
Background: The impact of the COVID pandemic on liver transplant (LT) programs varied among countries. Few data are available about that impact in pediatric liver transplant (PLT) programs. This study aimed at comparing the data of our program in Brazil (2019 vs. 2020).Methods: Retrospective cohort study.Results: One hundred and seventy‐four PLT were performed in the period (93% living donors). Patients were divided into two groups according to the LT date: pre‐COVID‐19 period (march/2019–February/2020) and COVID‐19 period (March/2020–February 2021). In the pre‐COVID‐19 period, 97 LTs were performed, and 77 LTs were performed in the COVID‐19 period. Patients in the COVID‐19 period were younger (10.9 months vs. 16 months, p 0.009), had higher PELD scores (15 vs. 14, p 0.04), more ascites (66.2 vs. 51.5%, p 0.03), and more frequently hospitalized before LT (27.3 vs. 17.5%). However, there was no difference in post‐LT complications, retransplantation nor survival rates. Six (6.2%) patients from pre‐COVID‐19 period were COVID positive at a median of 15.5 months (14–17.5), and 6 (7.8%) patients from COVID‐19 period were COVID positive at a median of 3 months (20 days–6 months) from LT. There was neither mortality nor complications in those patients. Four (33%) were hospitalized, and one had prolonged intubation. Four (33%) were asymptomatic, 4 (33%) had upper airways symptoms, and the remaining had gastrointestinal symptoms.Conclusion: Overall, PLT was not affected during COVID‐19 period. Even though patients from COVID‐19 period were sicker, there was no significant impact in LT outcomes. All the recipients who tested positive for COVID had a favorable outcome.